Cessation of Face Mask Use after COVID-19 Vaccination in Patients with Diabetes: Prevalence and Determinants

Hid Felizardo Cordero Franco (), Ana María Salinas Martínez, Diana Laura Martínez Martínez, Blanca Reyna Santiago Jarquin and Francisco Javier Guzmán de la Garza
Additional contact information
Hid Felizardo Cordero Franco: Epidemiologic and Health Services Research Unit/CIBIN, Mexican Institute of Social Security, Monterrey 64360, Mexico
Ana María Salinas Martínez: Epidemiologic and Health Services Research Unit/CIBIN, Mexican Institute of Social Security, Monterrey 64360, Mexico
Diana Laura Martínez Martínez: Vice-Rectory of Health Sciences, University of Monterrey, San Pedro Garza García 66238, Mexico
Blanca Reyna Santiago Jarquin: Family Medicine Clinic No. 26, Mexican Institute of Social Security, Monterrey 64360, Mexico
Francisco Javier Guzmán de la Garza: Epidemiologic and Health Services Research Unit/CIBIN, Mexican Institute of Social Security, Monterrey 64360, Mexico

IJERPH, 2023, vol. 20, issue 4, 1-13

Abstract: Studies on the cessation of face mask use after a COVID-19 vaccine in patients with diabetes are not available, despite their greater predisposition to complications. We estimated the prevalence of cessation of face mask use after receiving the COVID-19 vaccine in patients with diabetes and identified which factor was most strongly associated with non-use. This was a cross-sectional study in patients with diabetes 18–70 years with at least one dose of vaccine against COVID-19 ( n = 288). Participants were asked to respond face-to-face to a questionnaire in a primary care center. Descriptive statistics, chi-square tests, and multivariate binary logistic regression were used for analyzing the association between vulnerability, benefits, barriers, self-efficacy, vaccine expectations (independent variables), and cessation of use (dependent variable), controlling for sociodemographic, smoking, medical, vaccine, and COVID-19 history. The prevalence of cessation of face masks was 25.3% (95% CI 20.2, 30.5). Not feeling vulnerable to hospitalization increased the odds of non-use (adjusted OR = 3.3, 95% CI 1.2, 8.6), while perceiving benefits did the opposite (adjusted OR = 0.4, 95% CI 0.2, 0.9). The prevalence was low, and only two factors were associated with the cessation of face mask use after COVID-19 vaccination in patients with type 2 diabetes.

Keywords: COVID-19; vaccines; masks; health belief model; health behavior (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2023
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/20/4/2768/pdf (application/pdf)
https://www.mdpi.com/1660-4601/20/4/2768/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:20:y:2023:i:4:p:2768-:d:1057662

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().